I-Lin Lu

937 total citations
19 papers, 640 citations indexed

About

I-Lin Lu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, I-Lin Lu has authored 19 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Biomaterials. Recurrent topics in I-Lin Lu's work include Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). I-Lin Lu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). I-Lin Lu collaborates with scholars based in Taiwan and United States. I-Lin Lu's co-authors include Su‐Ying Wu, Neeraj Mahindroo, Yu‐Sheng Chao, Hsing‐Pang Hsieh, Hsin‐Cheng Chiu, Hsin‐Hung Chen, Wen‐Hsuan Chiang, Po‐Huang Liang, Yi‐Hui Peng and Keng‐Chang Tsai and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

I-Lin Lu

18 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I-Lin Lu Taiwan	13	295	175	164	98	94	19	640
Senbiao Fang China	15	429 1.5×	53 0.3×	132 0.8×	52 0.5×	60 0.6×	40	720
Huanzhang Xie China	16	344 1.2×	203 1.2×	89 0.5×	23 0.2×	36 0.4×	33	637
Sahil Kumar India	11	235 0.8×	57 0.3×	94 0.6×	32 0.3×	131 1.4×	46	760
Xiaocen Li China	14	507 1.7×	72 0.4×	139 0.8×	17 0.2×	138 1.5×	38	853
Rohit Bavi India	15	325 1.1×	87 0.5×	162 1.0×	26 0.3×	56 0.6×	26	705
Rajni Khan India	7	200 0.7×	116 0.7×	79 0.5×	159 1.6×	71 0.8×	12	574
Nahlah Makki Almansour Saudi Arabia	13	262 0.9×	48 0.3×	63 0.4×	33 0.3×	31 0.3×	27	565
Hayarpi Torosyan United States	9	350 1.2×	215 1.2×	41 0.3×	36 0.4×	27 0.3×	11	576
Ge Hong China	13	222 0.8×	38 0.2×	144 0.9×	15 0.2×	107 1.1×	35	659
Olafur Gudmundsson United States	15	231 0.8×	53 0.3×	38 0.2×	51 0.5×	27 0.3×	24	724

Countries citing papers authored by I-Lin Lu

Since Specialization

Citations

This map shows the geographic impact of I-Lin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-Lin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-Lin Lu more than expected).

Fields of papers citing papers by I-Lin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I-Lin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-Lin Lu. The network helps show where I-Lin Lu may publish in the future.

Co-authorship network of co-authors of I-Lin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of I-Lin Lu. A scholar is included among the top collaborators of I-Lin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I-Lin Lu. I-Lin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lu, I-Lin, et al.. (2025). Development of indomethacin amorphous solid dispersion by applying acid-base supersolubilization (ABS) principle to enhance solubility and enable low-temperature hot melt extrusion. International Journal of Pharmaceutics. 687. 126405–126405.

Liu, Te‐I, Tingyu Lu, Hsin‐Hung Chen, et al.. (2020). New combination treatment from ROS-Induced sensitized radiotherapy with nanophototherapeutics to fully eradicate orthotopic breast cancer and inhibit metastasis. Biomaterials. 257. 120229–120229. 44 indexed citations

Liu, Te‐I, I-Lin Lu, Chia‐Chen Liu, et al.. (2020). Tumor microenvironment-responsive and oxygen self-sufficient oil droplet nanoparticles for enhanced photothermal/photodynamic combination therapy against hypoxic tumors. Journal of Controlled Release. 328. 87–99. 31 indexed citations

Tsai, Yuan-Chung, Te‐I Liu, I-Lin Lu, et al.. (2020). Capturing Amyloid-β Oligomers by Stirring with Microscaled Iron Oxide Stir Bars into Magnetic Plaques to Reduce Cytotoxicity toward Neuronal Cells. Nanomaterials. 10(7). 1284–1284. 3 indexed citations

Chen, Hsin‐Hung, I-Lin Lu, Te‐I Liu, et al.. (2019). Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer. Colloids and Surfaces B Biointerfaces. 177. 294–305. 47 indexed citations

Lu, I-Lin, et al.. (2019). IR780-loaded zwitterionic polymeric nanoparticles with acidity-induced agglomeration for enhanced tumor retention. European Polymer Journal. 122. 109400–109400. 16 indexed citations

Huang, Wen‐Chia, I-Lin Lu, Wen‐Hsuan Chiang, et al.. (2017). Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma. Journal of Controlled Release. 254. 119–130. 70 indexed citations

Lu, I-Lin, et al.. (2016). Acidity-triggered surface charge neutralization and aggregation of functionalized nanoparticles for promoted tumor uptake. RSC Advances. 6(43). 36293–36295. 4 indexed citations

Lu, I-Lin. (2014). Adenosquamous Carcinoma of the Cecum with Malrotation and Intussusceptions. 30(1). 70–74. 1 indexed citations

10.

Lu, I-Lin & Hsiuying Wang. (2012). Protein-specific Scoring Method for Ligand Discovery. Journal of Computational Biology. 19(11). 1215–1226. 6 indexed citations

11.

Chen, Chung-Chu, et al.. (2011). Idiopathic Mesenteric Phlebosclerotic Colitis: A Case Report. 22(1). 29–39. 1 indexed citations

12.

Kuo, Chih‐Jung, Rey‐Ting Guo, I-Lin Lu, et al.. (2008). Structure‐Based Inhibitors Exhibit Differential Activities against Helicobacter pylori and Escherichia coli Undecaprenyl Pyrophosphate Synthases. BioMed Research International. 2008(1). 841312–841312. 27 indexed citations

13.

Lu, I-Lin, Keng‐Chang Tsai, Weir‐Torn Jiaang, et al.. (2007). A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry. 43(8). 1603–1611. 18 indexed citations

14.

Tsai, Keng‐Chang, Shih‐Yuan Chen, Po‐Huang Liang, et al.. (2006). Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies. Journal of Medicinal Chemistry. 49(12). 3485–3495. 50 indexed citations

15.

Mahindroo, Neeraj, Chun-Chen Liao, Chien-Fu Huang, et al.. (2006). Indol-1-yl Acetic Acids as Peroxisome Proliferator-Activated Receptor Agonists: Design, Synthesis, Structural Biology, and Molecular Docking Studies. Journal of Medicinal Chemistry. 49(3). 1212–1216. 64 indexed citations

16.

Lu, I-Lin, Neeraj Mahindroo, Po‐Huang Liang, et al.. (2006). Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease. Journal of Medicinal Chemistry. 49(17). 5154–5161. 117 indexed citations

17.

Mahindroo, Neeraj, Yi‐Hui Peng, Chia‐Hui Lin, et al.. (2006). Structural Basis for the Structure−Activity Relationships of Peroxisome Proliferator-Activated Receptor Agonists. Journal of Medicinal Chemistry. 49(21). 6421–6424. 25 indexed citations

18.

Lu, I-Lin, Chien-Fu Huang, Yi‐Hui Peng, et al.. (2006). Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities. Journal of Medicinal Chemistry. 49(9). 2703–2712. 86 indexed citations

19.

Lu, I-Lin, Shiow‐Ju Lee, Su‐Ying Wu, et al.. (2005). Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(13). 3271–3275. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact